AcademiaDrive research excellence and student success
Drive research excellence and student success
Consumer Goods, Manufacturing & TechnologyDrive innovation and build strong brands
Drive innovation and build strong brands
GovernmentMaximize the impact of your country’s research and innovation
Maximize the impact of your country’s research and innovation
Legal ServicesEmpower law firms to drive success for their clients
Empower law firms to drive success for their clients
Life Sciences & HealthcareAdvance innovation and accelerate patient outcomes
Advance innovation and accelerate patient outcomes
Scientific & Academic Researcharrow_forward
Discovery & Workflow
Analytics, Evaluation & Management
Libraries, Teaching & Learning
Research & Development
Pharmacovigilance & Drug Safety
Regulatory & Compliance
Portfolio Strategy & Business Development
Commercial & Launch Strategy
Generics & Manufacturing
Strategic Portfolio Planning
Product Lifecycle Management
IP Litigation Intelligence Solutions
Patent Intelligence Software
Patent Search & Analytics
Trademark Research & Protection
Chemistry & Life Science
IP Data & APIs
IP Lifecycle Managementarrow_forward
IP Management Software
Network Collaboration Tools
Patent & Trademark Maintenance
Filing & Prosecution Support
Patent Translations Services
Consulting & Dataarrow_forward
Data integration and custom analytics
Market Intelligence Data
Life Sciences and Healthcare Consulting Services
BlogKeep up with the latest news, insights and research from Clarivate.
Keep up with the latest news, insights and research from Clarivate.
Clarivate Innovation ExchangeThe Clarivate Innovation Exchange accelerates research, development and commercialization.
The Clarivate Innovation Exchange accelerates research, development and commercialization.
Partnersarrow_forwardPartner with us and help accelerate innovation.
Partner with us and help accelerate innovation.
Channel Partner Program
Cortellis Partner Program
ScholarOne Partner Program
Researcher RecognitionWorld-changing research should be seen, shared and celebrated.
World-changing research should be seen, shared and celebrated.
Academic & Government
Life Sciences & Healthcare
Reports & Case Studiesarrow_forward
ISI Global Research Reports
PodcastsThe Clarivate podcast series enables us to address issues in key business areas in new and interesting ways.
The Clarivate podcast series enables us to address issues in key business areas in new and interesting ways.
Consumer Goods, Manufacturing & Technology
Scientific & Academic Research
IP Lifecycle Management
Consulting & Data
Clarivate Innovation Exchange
Reports & Case Studies
Voice of Customer
The drug profile includes the sales and forecast for the time period 2017 – 2028 for the United States and Rest of the World (ROW). It also covers the forecast summary and assumptions in terms of upsides and downsides.
In 2021, sales of branded biologics for oncology, immunology, endocrinology, nephrology, respiratory, and ophthalmology indications exceeded $130 billion in the major pharmaceutical markets under…
In 2021, sales of branded MAb biologics in oncology exceeded $36 billion in the major pharmaceutical markets (United States, EU5, and Japan), and sales of biosimilars totaled approximately $5…
In 2021, sales of erythropoiesis-stimulating agent (ESA) brands and biosimilars at the ex-manufacturer price level totaled more than $2.5 billion in the major pharmaceutical markets under study (…
In 2021, sales of insulins at the ex-manufacturer price level exceeded $20 billion in the major pharmaceutical markets under study (United States, EU5, and Japan). Throughout our 2021-2031 forecast…
Biomarker-driven prescribing is paramount in key oncology indications. The use of biomarkers is entrenched in non-small-cell lung cancer (NSCLC), breast cancer, and colorectal cancer. Biomarker-…